Clinical Trials Browser

Completed × INDUSTRY × Adenoviridae Infections × Clear all

Adenoviridae Infections

NCT02705196 2026-02-24

LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer

Phase 1/2 Completed

51 enrolled

Gastrointestinal

Adenoviridae Infections, Neoplasms, Pancreatic Neoplasms

NCT03754933 2025-03-27

Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer

Phase 1/2 Completed

10 enrolled 22 charts

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Adenoviridae Infections, Head and Neck Neoplasms

NCT04693637 2024-05-09

Prevent

Phase 2/3 Completed

26 enrolled 16 charts

Adenoviridae Infections, Cytomegalovirus Infections, Epstein-Barr Virus Infections

NCT02108522 2021-07-20

CHARMS

Phase NA Completed

82 enrolled 20 charts

Adenoviridae Infections, Cytomegalovirus Infections, Infections, Epstein-Barr Virus Infections

NCT00031083 2020-11-17

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

Phase 1 Completed

12 enrolled

CNSSarcoma

Adenoviridae Infections, Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Gliosarcoma

NCT01570283 2019-05-30

ARMS

Phase 1/2 Completed

21 enrolled 10 charts

Adenoviridae Infections, Virus Diseases, Epstein-Barr Virus Infections

NCT02654938 2017-09-20

Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancer

Phase 1 Completed

32 enrolled

Genitourinary

Adenoviridae Infections, Prostatic Neoplasms

Clinical Trials

TUNIMO

LOAd703 Oncolytic Virus Therapy for Pancreatic Cancer

Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer

Prevent

CHARMS

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

ARMS

Safety and Tolerability Clinical Trial of Different Doses of the Immunotherapeutic Drug Mobilan (M-VM3) and Placebo in Patients With Prostate Cancer